2026 NPPES data Psychosomatic Medicine Physician NPI 1548480148 M.D.
Verify on CMS →

DEBORAH FINKLESTEIN, M.D.

Psychosomatic Medicine Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
359
Medicare Part D claims · 33 beneficiaries · Psychosomatic Medicine Physician avg: 645
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$68.26
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DEBORAH FINKLESTEIN, M.D. is a Psychosomatic Medicine Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 359 claims across 33 beneficiaries — 3% brand-name prescribing . Industry payments of $68.26 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DEBORAH FINKLESTEIN, M.D. filed 359 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

DEBORAH FINKLESTEIN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

DEBORAH FINKLESTEIN, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 04/26/2007

NPI 1548480148

Primary specialty

Psychosomatic Medicine Physician

Rare

491 US NPIs in this specialty

Medicare Part D claims

359 44% vs specialty avg

2023 prescription claims

Specialty avg: 645

Specialty distribution in New York

How Psychosomatic Medicine Physician compares to other specialties among New York providers

New York providers

Psychosomatic Medicine Physician share within New York

1. Psychosomatic Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychosomatic Medicine Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Psychosomatic Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Psychosomatic Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Psychosomatic Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Psychosomatic Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH FINKLESTEIN, M.D. is a Psychosomatic Medicine Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1548480148. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEBORAH FINKLESTEIN, M.D. appears in the CMS NPPES registry as a Psychosomatic Medicine Physician provider holding M.D. credentials at 138 W 25TH ST, NEW YORK, NY, 10001, with a listed phone of (646) 224-8719. NPI 1548480148 was issued on 04/26/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FINKLESTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 359 prescription claims written by this provider, covering 33 Medicare beneficiaries and totaling roughly $14K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Psychosomatic Medicine Physician is a narrow specialty nationwide, with 491 enrolled providers across 43 states and an average of 645 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

138 W 25TH ST
NEW YORK, NY 10001

Provider Details

NPI 1548480148
Specialty Psychosomatic Medicine Physician
Credentials M.D.
Gender Female
NPI Issued 04/26/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH FINKLESTEIN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$68

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DEBORAH FINKLESTEIN, M.D.. To verify DEBORAH FINKLESTEIN, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

DEBORAH FINKLESTEIN, M.D. — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 359 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

359
Total Claims
$14K
Total Drug Cost
33
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
508
Total Day Supply
15,157
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$3K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
70.7 years
Avg HCC Risk Score
0.75

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Desvenlafaxine Succinate Er
Desvenlafaxine Succinate
42
Bupropion Xl
Bupropion Hcl
41
Gabapentin
28
Sertraline Hcl
27
Trazodone Hcl
23
Duloxetine Hcl
20
Dextroamphetamine-Amphetamine
Dextroamphetamine/Amphetamine
19
Clonazepam
18
Escitalopram Oxalate
17
Dextroamphetamine-Amphet Er
Dextroamphetamine/Amphetamine
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychosomatic Medicine Physician Overview

How DEBORAH FINKLESTEIN, M.D. fits within the Psychosomatic Medicine Physician landscape nationally.

491
Psychosomatic Medicine Physician Providers in US
43
States with Psychosomatic Medicine Physician
645
Avg Claims per Provider

DEBORAH FINKLESTEIN, M.D.'s 359 claims are below the specialty average of 645.

Nearby Psychosomatic Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as FINKLESTEIN.

Compare Psychosomatic Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH FINKLESTEIN, M.D.'s specialty?
DEBORAH FINKLESTEIN, M.D. specializes in Psychosomatic Medicine Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does DEBORAH FINKLESTEIN, M.D. prescribe under Medicare Part D?
In 2023, DEBORAH FINKLESTEIN, M.D. wrote 359 Medicare Part D claims totaling $14K in drug costs for 33 beneficiaries.
Where is DEBORAH FINKLESTEIN, M.D. located?
DEBORAH FINKLESTEIN, M.D. is located at 138 W 25TH ST, NEW YORK, NY, 10001. Phone: (646) 224-8719.
What is DEBORAH FINKLESTEIN, M.D.'s NPI number?
DEBORAH FINKLESTEIN, M.D.'s National Provider Identifier (NPI) is 1548480148, issued on 04/26/2007.
Does DEBORAH FINKLESTEIN, M.D. prescribe more brand-name or generic drugs?
DEBORAH FINKLESTEIN, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $3K in brand drug costs.
How many Psychosomatic Medicine Physician providers are there in the US?
There are 491 Psychosomatic Medicine Physician providers across 43 states in the US. The average Psychosomatic Medicine Physician provider writes 645 Medicare Part D claims per year.
What drugs does DEBORAH FINKLESTEIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH FINKLESTEIN, M.D.'s most frequently prescribed drugs include Desvenlafaxine Succinate Er, Bupropion Xl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH FINKLESTEIN, M.D. accept Medicare?
DEBORAH FINKLESTEIN, M.D. appears in CMS Medicare data with 359 Part D claims and 33 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH FINKLESTEIN, M.D.'s credentials?
DEBORAH FINKLESTEIN, M.D.'s NPI is 1548480148 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology